2016
Sleep‐Wake Disorders
Shenoy A, Fischer R, Garakani A. Sleep‐Wake Disorders. 2016, 207-216. DOI: 10.1002/9781118654231.ch23.Chapters
2014
Advances in Psychopharmacology for Anxiety Disorders
Garakani A, Murrough J, Iosifescu D. Advances in Psychopharmacology for Anxiety Disorders. FOCUS The Journal Of Lifelong Learning In Psychiatry 2014, 12: 152-162. DOI: 10.1176/appi.focus.12.2.152.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSerotonin-norepinephrine reuptake inhibitorsSelective serotonin reuptake inhibitorsPosttraumatic stress disorderAnxiety disordersReuptake inhibitorsRelated conditionsGamma-aminobutyric acid (GABA) systemPharmacological treatment modalitiesFirst-line treatmentSerotonin reuptake inhibitorsNew pharmacotherapeutic approachesNorepinephrine reuptake inhibitorsVasopressin receptor antagonistsNovel treatment optionsPrevalent psychiatric disordersGlutamate modulatorsMedication classesCertain anxiety disordersNeuropeptide YTreatment modalitiesTreatment optionsNew drug developmentReceptor antagonistNew medicationsPharmacotherapeutic approaches
2012
Mental Health Approaches to Child Victims of Acts of Terrorism
Saraiya A, Garakani A, Billick SB. Mental Health Approaches to Child Victims of Acts of Terrorism. Psychiatric Quarterly 2012, 84: 115-124. PMID: 22736303, DOI: 10.1007/s11126-012-9232-4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements